Jim Cramer is keeping an eye on shares of Mylan after CEO Heather Bresch's CNBC interview where she addressed criticism surrounding the cost of the EpiPen and her frustration with Congress.
Heather Bresch, Mylan CEO, says the fight is on to fix the health care system and she is willing to work with Congress to make it happen.
Heather Bresch, Mylan CEO, says the health care system is broken and if you don't play in the system your products won't get to patients.
Heather Bresch, Mylan CEO, urges changes to update the U.S. health care system and talks about the need to bring down drug costs. Patients are paying twice, says Bresch.
Heather Bresch, Mylan CEO, discusses the need to update the U.S. health care system, and the company's plan to provide an alternate route on pricing.
Heather Bresch, Mylan CEO talks about her frustration with the rising price of drugs.
Heather Bresch, Mylan CEO breaks down the pricing path of the EpiPen and the company's plan to expand access to the drug.
Heather Bresch, Mylan CEO, responds to the controversy surround the company's 400-percent increase for its injectable allergy medicine.
In a wide-ranging interview, Heather Bresch, Mylan CEO sits CNBC's Brian Sullivan to discuss the controversy surround the recent 400-percent increase in the EpiPen and her frustration with the health care system.
CNBC's Rick Santelli breaks down the latest numbers on unemployment and durable goods.
Susan Lyne, BBG Ventures president & founder, talks about encouraging more women to enter the field of technology and focus on start-ups and venture capital.
Scott Gottlieb AEI resident fellow, and Sam Waksal, Kadmon Corporation, discuss whether regulations will impede innovation in the pharmaceutical industry.
Scott Gottlieb, AEI resident fellow, and Sam Waksal, Kadmon Corporation, discuss the controversy surround the price hikes of Mylan's EpiPen and the problems that arise when companies obtain monopolies on certain drugs.
Under pressure, Mylan plans to boost access to its EpiPen Auto-Injector by expanding existing programs for patients who are facing higher costs.
Scott Gottlieb, AEI resident fellow, and Sam Waksal, Kadmon Corporation, discuss how competition impacts drug pricing and whether the FDA is working fast enough to streamline its approval process.
Derrick Pitts, Franklin Institute chief astronomer discusses the discovery of a rocky nearby planet that could be the closest possible home for life outside of this solar system.
CNBC's Meg Tirrell follows the economics of the U.S. pharmaceutical supply chain.
Kansas City Fed President Esther George talks to CNBC's Steve Liesman about the Federal Reserve's framework for monetary policy.
CNBC's Courtney Reagan takes a look at earnings results for Tiffany and Sears.
Jim Paulsen, Wells Capital Management, and Michael Hanson, BofA Merrill Lynch, share their expectation on interest rates ahead of the Fed's summit in Jackson Hole, Wyoming.
Get the best of CNBC in your inbox
Joe Kernen is co-anchor of "Squawk Box," CNBC's signature morning program.
Becky Quick is co-anchor of "Squawk Box" and also anchor of the nationally syndicated "On the Money."
Andrew Ross Sorkin is a co-anchor of "Squawk Box," a financial columnist for "The New York Times" and the editor-at-large of NYT's DealBook.